Wells Fargo’s Oric Pharmaceuticals ORIC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $612K | Buy |
|
|||||
|
2025
Q2 | $341K | Sell |
|
|||||
|
2025
Q1 | $218K | Buy |
|
|||||
|
2024
Q4 | $289K | Buy |
|
|||||
|
2024
Q3 | $282K | Buy |
|
|||||
|
2024
Q2 | $189K | Buy |
|
|||||
|
2024
Q1 | $209K | Buy |
|
|||||
|
2023
Q4 | $124K | Buy |
|
|||||
|
2023
Q3 | $68.4K | Sell |
|
|||||
|
2023
Q2 | $128K | Buy |
|
|||||
|
2023
Q1 | $10.7K | Buy |
|
|||||
|
2022
Q4 | $2.65K | Buy |
|
|||||
|
2022
Q3 | $2K | Sell |
|
|||||
|
2022
Q2 | $2K | Sell |
|
|||||
|
2022
Q1 | $953K | Sell |
|
|||||
|
2021
Q4 | $2.68M | Sell |
|
|||||
|
2021
Q3 | $25.3M | Sell |
|
|||||
|
2021
Q2 | $22M | Buy |
|
|||||
|
2021
Q1 | $29.5M | Buy |
|
|||||
|
2020
Q4 | $28.9M | Buy |
|
|||||
|
2020
Q3 | $15.6M | Buy |
|
|||||
|
2020
Q2 | $19.3M | Buy |
|